Literature DB >> 8385525

Differences in the acute and chronic antihypertensive effects of lisinopril and enalapril assessed by ambulatory blood pressure monitoring.

S Gourlay1, J McNeil, A Forbes, B McGrath.   

Abstract

Although lisinopril and enalapril are equipotent angiotensin converting enzyme (ACE) inhibitors lisinopril has been reported to produce greater inhibition of plasma ACE 24 hours after single doses. This study compared the antihypertensive effects of once daily 10mg doses of the drugs using a randomised, double-blind, two period cross-over design with ambulatory blood pressure monitoring. Lisinopril lowered mean 24 hour systolic blood pressure significantly more than enalapril after 4 weeks of treatment (14/7 +/- 2/1mmHg &amp; 9/6 +/- 2/1mmHg, respectively, adjusted SBP difference 4.8mmHg, P < 0.01). This difference was confined to the second 12 hours of the daily dosage interval (adjusted SBP difference 13-24 hours after dosing 9.9mmHg, P < 0.001). The diastolic pressure showed a similar trend but this was not statistically significant. The side effects of each agent were minor. We conclude that chronic, once daily therapy with 10mg of lisinopril reduces systolic blood pressure more effectively than an equal dose of enalapril due to its greater effect in the latter half of the 24 hour dosage interval.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385525     DOI: 10.3109/10641969309041612

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

1.  Dermacase. Benign eccrine tumour (hidrocystoma).

Authors:  T Enta
Journal:  Can Fam Physician       Date:  1994-11       Impact factor: 3.275

2.  Dermacase. Eczema herpeticum.

Authors:  T Enta
Journal:  Can Fam Physician       Date:  1994-09       Impact factor: 3.275

Review 3.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

4.  Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.

Authors:  C Bourgault; E Elstein; J Le Lorier; S Suissa
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

5.  Zofenopril versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients : A Randomised, Double-Blind, Multicentre Study.

Authors:  Ettore Malacco; Simona Piazza; Stefano Omboni
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

6.  Maternal serum screening.

Authors:  J C Carroll
Journal:  Can Fam Physician       Date:  1994-10       Impact factor: 3.275

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.